UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Plasma lyso-Gb3: a biomarker for monitoring fabry patients during enzyme replacement therapy

Clinical and experimental nephrology, 2018-08, Vol.22 (4), p.843-849

2018

Volltextzugriff (PDF)

Profiles of Globotriaosylsphingosine Analogs and Globotriaosylceramide Isoforms Accumulated in Body Fluids from Various Phenotypic Fabry Patients

Internal Medicine, 2024/06/01, Vol.63(11), pp.1531-1537

2024

Volltextzugriff (PDF)

Genetically Modified Cell Transplantation Through Macroencapsulated Spheroids with Scaffolds to Treat Fabry Disease

Cell transplantation, 2021-01, Vol.30, p.9636897211060269-9636897211060269

2021

Volltextzugriff (PDF)

The study investigating the determination of protamine in seminal plasma from azoospermic donors: Suggestion of new methods to diagnose obstructive azoospermia, and to capture childbearing sperm for testicular sperm extraction (TESE) and insemination sperm injection (ICSI)

Analytical biochemistry, 2020-09, Vol.604, p.113792-113792, Article 113792

2020

Volltextzugriff (PDF)

Comparative study on incorporation of three recombinant human α-galactosidase A drugs (agalsidases) into cultured fibroblasts and organs/tissues of Fabry mice

Molecular genetics and metabolism reports, 2024-09, Vol.40, p.101118, Article 101118

2024

Volltextzugriff (PDF)

Nano-LC-MS/MS for Quantification of Lyso-Gb3 and Its Analogues Reveals a Useful Biomarker for Fabry Disease

PloS one, 2015-05, Vol.10 (5), p.e0127048-e0127048

2015

Volltextzugriff (PDF)

Distributions of Globotriaosylceramide Isoforms, and Globotriaosylsphingosine and Its Analogues in an α-Galactosidase A Knockout Mouse, a Model of Fabry Disease

PloS one, 2015-12, Vol.10 (12), p.e0144958-e0144958

2015

Volltextzugriff (PDF)

In Vivo Delivery of Therapeutic Molecules by Transplantation of Genome-Edited Induced Pluripotent Stem Cells

Cell transplantation, 2023-01, Vol.32, p.9636897231173734-9636897231173734

2023

Volltextzugriff (PDF)

Cell Transplantation Combined with Recombinant Collagen Peptides for the Treatment of Fabry Disease

Cell transplantation, 2020-01, Vol.29, p.963689720976362-963689720976362

2020

Volltextzugriff (PDF)

Does administration of hydroxychloroquine/amiodarone affect the efficacy of enzyme replacement therapy for Fabry mice?

Molecular genetics and metabolism reports, 2024-06, Vol.39, p.101079-101079, Article 101079

2024

Volltextzugriff (PDF)

Plasma globotriaosylsphingosine as a biomarker of Fabry disease

Molecular genetics and metabolism, 2010-07, Vol.100 (3), p.257-261

2010

Volltextzugriff (PDF)

Monitoring of anti-drug antibodies and disease-specific biomarkers in three patients from a Japanese Fabry family treated with enzyme replacement therapy

CEN case reports, 2023-05, Vol.12 (2), p.171-175

2023

Volltextzugriff (PDF)

Comparative urinary globotriaosylceramide analysis by thin-layer chromatography-immunostaining and liquid chromatography-tandem mass spectrometry in patients with Fabry disease

Molecular genetics and metabolism reports, 2021-12, Vol.29, p.100804-100804, Article 100804

2021

Volltextzugriff (PDF)

Human α-L-iduronidase uses its own N-glycan as a substrate-binding and catalytic module

Proceedings of the National Academy of Sciences - PNAS, 2013-09, Vol.110 (36), p.14628-14633

2013

Volltextzugriff (PDF)

Surface plasmon resonance analysis of complex formation of therapeutic recombinant lysosomal enzymes with domain 9 of human cation-independent mannose 6-phosphate receptor

Molecular genetics and metabolism reports, 2020-12, Vol.25, p.100639-100639, Article 100639

2020

Volltextzugriff (PDF)

Prevalence and clinical features of Fabry disease in Japanese male patients with diagnosis of hypertrophic cardiomyopathy

Journal of cardiology, 2017-01, Vol.69 (1), p.302-307

2017

Volltextzugriff (PDF)

Differences in cleavage of globotriaosylceramide and its derivatives accumulated in organs of young Fabry mice following enzyme replacement therapy

Molecular genetics and metabolism, 2017-01, Vol.120 (1-2), p.116-120

2017

Volltextzugriff (PDF)

Does administration of hydroxychloroquine/amiodarone accelerate accumulation of globotriaosylceramide and globotriaosylsphingosine in Fabry mice?

Molecular genetics and metabolism reports, 2021-09, Vol.28, p.100773-100773, Article 100773

2021

Volltextzugriff (PDF)

Fabry disease in a Japanese population-molecular and biochemical characteristics

Molecular genetics and metabolism reports, 2018-12, Vol.17, p.73-79

2018

Volltextzugriff (PDF)

Anti-drug antibody formation in Japanese Fabry patients following enzyme replacement therapy

Molecular genetics and metabolism reports, 2020-12, Vol.25, p.100650-100650, Article 100650

2020

Volltextzugriff (PDF)

Comparative study on mannose 6-phosphate residue contents of recombinant lysosomal enzymes

Molecular genetics and metabolism, 2014-03, Vol.111 (3), p.369-373

2014

Volltextzugriff (PDF)

Rapid Immunochromatographic Detection of Serum Anti-α-Galactosidase A Antibodies in Fabry Patients after Enzyme Replacement Therapy

PloS one, 2015-06, Vol.10 (6), p.e0128351-e0128351

2015

Volltextzugriff (PDF)

Effectiveness of immunosuppressive therapy for nephrotic syndrome in a patient with late-onset Fabry disease: a case report and literature review

BMC nephrology, 2019-12, Vol.20 (1), p.469-469, Article 469

2019

Volltextzugriff (PDF)

Development of a highly sensitive immuno-PCR assay for the measurement of α-galactosidase A protein levels in serum and plasma

PloS one, 2013-11, Vol.8 (11), p.e78588-e78588

2013

Volltextzugriff (PDF)

High-throughput screening identified disease-causing mutants and functional variants of α-galactosidase A gene in Japanese male hemodialysis patients

Journal of human genetics, 2012-09, Vol.57 (9), p.575-579

2012

Volltextzugriff (PDF)

1 – 25 von 97

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(97)
Mit Volltextzugriff
(94)

Publikationsform

Artikel
(97)

Sprache

Englisch
(96)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Plasma lyso-Gb3: a biomarker for monitoring fabry patients during enzyme replacement therapy

Profiles of Globotriaosylsphingosine Analogs and Globotriaosylceramide Isoforms Accumulated in Body Fluids from Various Phenotypic Fabry Patients

Genetically Modified Cell Transplantation Through Macroencapsulated Spheroids with Scaffolds to Treat Fabry Disease

The study investigating the determination of protamine in seminal plasma from azoospermic donors: Suggestion of new methods to diagnose obstructive azoospermia, and to capture childbearing sperm for testicular sperm extraction (TESE) and insemination sperm injection (ICSI)

Comparative study on incorporation of three recombinant human α-galactosidase A drugs (agalsidases) into cultured fibroblasts and organs/tissues of Fabry mice

Nano-LC-MS/MS for Quantification of Lyso-Gb3 and Its Analogues Reveals a Useful Biomarker for Fabry Disease

Distributions of Globotriaosylceramide Isoforms, and Globotriaosylsphingosine and Its Analogues in an α-Galactosidase A Knockout Mouse, a Model of Fabry Disease

In Vivo Delivery of Therapeutic Molecules by Transplantation of Genome-Edited Induced Pluripotent Stem Cells

Cell Transplantation Combined with Recombinant Collagen Peptides for the Treatment of Fabry Disease

Does administration of hydroxychloroquine/amiodarone affect the efficacy of enzyme replacement therapy for Fabry mice?

Plasma globotriaosylsphingosine as a biomarker of Fabry disease

Monitoring of anti-drug antibodies and disease-specific biomarkers in three patients from a Japanese Fabry family treated with enzyme replacement therapy

Comparative urinary globotriaosylceramide analysis by thin-layer chromatography-immunostaining and liquid chromatography-tandem mass spectrometry in patients with Fabry disease

Human α-L-iduronidase uses its own N-glycan as a substrate-binding and catalytic module

Surface plasmon resonance analysis of complex formation of therapeutic recombinant lysosomal enzymes with domain 9 of human cation-independent mannose 6-phosphate receptor

Prevalence and clinical features of Fabry disease in Japanese male patients with diagnosis of hypertrophic cardiomyopathy

Differences in cleavage of globotriaosylceramide and its derivatives accumulated in organs of young Fabry mice following enzyme replacement therapy

Does administration of hydroxychloroquine/amiodarone accelerate accumulation of globotriaosylceramide and globotriaosylsphingosine in Fabry mice?

Fabry disease in a Japanese population-molecular and biochemical characteristics

Anti-drug antibody formation in Japanese Fabry patients following enzyme replacement therapy

Comparative study on mannose 6-phosphate residue contents of recombinant lysosomal enzymes

Rapid Immunochromatographic Detection of Serum Anti-α-Galactosidase A Antibodies in Fabry Patients after Enzyme Replacement Therapy

Effectiveness of immunosuppressive therapy for nephrotic syndrome in a patient with late-onset Fabry disease: a case report and literature review

Development of a highly sensitive immuno-PCR assay for the measurement of α-galactosidase A protein levels in serum and plasma

High-throughput screening identified disease-causing mutants and functional variants of α-galactosidase A gene in Japanese male hemodialysis patients

Suchergebnisse filtern